Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Pharmacokinetics and pharmacodynamics of AR9281, an inhibitor of soluble epoxide hydrolase, in single- and multiple-dose studies in healthy human subjects - Chen_2012_J.Clin.Pharmacol_52_319 |
| Author(s) : Chen D , Whitcomb R , MacIntyre E , Tran V , Do ZN , Sabry J , Patel DV , Anandan SK , Gless R , Webb HK |
| Ref : Journal of Clinical Pharmacology , 52 :319 , 2012 |
| Abstract : Chen_2012_J.Clin.Pharmacol_52_319 |
| ESTHER : Chen_2012_J.Clin.Pharmacol_52_319 |
| PubMedSearch : Chen_2012_J.Clin.Pharmacol_52_319 |
| PubMedID: 21422238 |
| Title : Whole-genome sequences of four Mycobacterium bovis BCG vaccine strains - Pan_2011_J.Bacteriol_193_3152 |
| Author(s) : Pan Y , Yang X , Duan J , Lu N , Leung AS , Tran V , Hu Y , Wu N , Liu D , Wang Z , Yu X , Chen C , Zhang Y , Wan K , Liu J , Zhu B |
| Ref : Journal of Bacteriology , 193 :3152 , 2011 |
| Abstract : Pan_2011_J.Bacteriol_193_3152 |
| ESTHER : Pan_2011_J.Bacteriol_193_3152 |
| PubMedSearch : Pan_2011_J.Bacteriol_193_3152 |
| PubMedID: 21478353 |
| Gene_locus related to this paper: myctu-RV1215C |
| Title : 1-(1-acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea (AR9281) as a potent, selective, and orally available soluble epoxide hydrolase inhibitor with efficacy in rodent models of hypertension and dysglycemia - Anandan_2011_Bioorg.Med.Chem.Lett_21_983 |
| Author(s) : Anandan SK , Webb HK , Chen D , Wang YX , Aavula BR , Cases S , Cheng Y , Do ZN , Mehra U , Tran V , Vincelette J , Waszczuk J , White K , Wong KR , Zhang LN , Jones PD , Hammock BD , Patel DV , Whitcomb R , MacIntyre DE , Sabry J , Gless R |
| Ref : Bioorganic & Medicinal Chemistry Lett , 21 :983 , 2011 |
| Abstract : Anandan_2011_Bioorg.Med.Chem.Lett_21_983 |
| ESTHER : Anandan_2011_Bioorg.Med.Chem.Lett_21_983 |
| PubMedSearch : Anandan_2011_Bioorg.Med.Chem.Lett_21_983 |
| PubMedID: 21211973 |